Sotera Health Reports Q4 and Full-Year 2024 Results; Offers 2025 Outlook Sotera Health Company (Nasdaq: SHC), a leading provider of sterilization solutions, lab testing, and advisory services for the healthcare…
Pear Suite Empowers Birthworkers with Innovative Technology for Maternal and Child Health Pear Suite, a digital health company dedicated to addressing social determinants of health (SDOH), is advancing its mission…
Smart Meter Reveals 5 SmartHealth Solutions to Boost Patient Engagement at HIMSS 2025 Smart Meter, a leader in remote patient monitoring (RPM) technology, is poised to revolutionize patient engagement with…
GE HealthCare Appoints New President and CEO for China GE HealthCare (Nasdaq: GEHC), a global leader in healthcare solutions, announced today that Yihao Zhang, the current president and CEO of…
Sermo Survey: 81% of Physicians Say Technical Proficiency is Equal to Clinical Expertise The 37th Barometer report from Sermo, a leading platform for healthcare professional (HCP) engagement offering real-time business…
Seqfirst-neo Study Highlights Impact of Genomic Testing in NICU, Exposing Gaps in Protocols GeneDx (Nasdaq: WGS), a leading provider of genomic insights aimed at improving health outcomes, announced today that…
Healx Doses First Patient in Phase 2 Trial of HLX-1502 for Neurofibromatosis Type 1 Healx, a clinical-stage biotech company utilizing AI to advance treatments for rare diseases, has announced that…
Samsung Bioepis Launches PYZCHIVA® (Biosimilar to Stelara) in the US Samsung Bioepis Co., Ltd. has announced the U.S. launch of PYZCHIVA® (ustekinumab-ttwe), a biosimilar to Stelara (ustekinumab). PYZCHIVA is approved…
Neuroendocrine Tumor Center of Excellence Re-Certified The Center for Neuroendocrine Tumors at the Bad Berka Central Clinic has been officially re-certified, continuing its distinction as a leading medical facility in…
Prisma Health Saves $450M with Systemwide Transformation Prisma Health, South Carolina’s largest healthcare provider, has long been at the forefront of delivering exceptional care across the state. However, the challenges…
Baxter Reports Q4 and Full-Year 2024 Results Baxter International Inc. (NYSE: BAX), a leader in the global medtech industry, reported its financial results for the fourth quarter and full year…
Celltrion Presents New LIBERTY Study Analyses at ECCO Congress on SC Infliximab Efficacy and Safety Celltrion presented new post hoc analyses of its pivotal LIBERTY studies (LIBERTY-CD and LIBERTY-UC) at…
